Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
I(Cln)
, a cytosolic protein associated with a nucleotide-sensitive chloride current, may be involved in the regulation of a volume-regulated anion current (VRAC) associated with hypotonic cell swelling. We have determined the nucleic acid sequences of
I(Cln)
from human tsA201a, colonic (T84) and
myeloma
(RPMI 8826) cell lines. The amino acid sequences are highly homologous (>/=99%) to each other but less homologous to
I(Cln)
protein from other species. Using the whole-cell patch clamp technique, we examined the effect of
I(Cln)
protein expression levels on VRAC properties during a hyposmotic challenge. Overexpression of T84 or RPMI 8226-derived
I(Cln)
protein in tsA201a cells results in a more than 9-fold increase in the rate of VRAC activation over control values, while having no effect on VRAC inactivation properties. Underexpression of endogenous
I(Cln)
protein in tsA201a cells using antisense oligonucleotides results in a more than 180-fold decrease in VRAC activation rate as compared to control values. These results indicate that
I(Cln)
protein expression modulates VRAC activation but not inactivation.
...
PMID:Modulation of volume regulated anion current by I(Cln). 1082 35